ES494955A0 - Un procedimiento para preparar derivados de fenilpiperidina - Google Patents

Un procedimiento para preparar derivados de fenilpiperidina

Info

Publication number
ES494955A0
ES494955A0 ES494955A ES494955A ES494955A0 ES 494955 A0 ES494955 A0 ES 494955A0 ES 494955 A ES494955 A ES 494955A ES 494955 A ES494955 A ES 494955A ES 494955 A0 ES494955 A0 ES 494955A0
Authority
ES
Spain
Prior art keywords
preparing
procedure
phenylpiperidine derivatives
derivatives
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494955A
Other languages
English (en)
Other versions
ES8106892A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES494955A0 publication Critical patent/ES494955A0/es
Publication of ES8106892A1 publication Critical patent/ES8106892A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10D—INORGANIC ELECTRIC SEMICONDUCTOR DEVICES
    • H10D30/00—Field-effect transistors [FET]
    • H10D30/01—Manufacture or treatment
    • H10D30/021—Manufacture or treatment of FETs having insulated gates [IGFET]
    • H10D30/028—Manufacture or treatment of FETs having insulated gates [IGFET] of double-diffused metal oxide semiconductor [DMOS] FETs
    • H10D30/0291—Manufacture or treatment of FETs having insulated gates [IGFET] of double-diffused metal oxide semiconductor [DMOS] FETs of vertical DMOS [VDMOS] FETs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES494955A 1979-02-23 1980-09-11 Un procedimiento para preparar derivados de fenilpiperidina Expired ES8106892A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/014,548 US4216218A (en) 1979-02-23 1979-02-23 Antidepressant and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines

Publications (2)

Publication Number Publication Date
ES494955A0 true ES494955A0 (es) 1981-09-01
ES8106892A1 ES8106892A1 (es) 1981-09-01

Family

ID=21766108

Family Applications (2)

Application Number Title Priority Date Filing Date
ES488708A Granted ES488708A0 (es) 1979-02-23 1980-02-18 Un procedimiento para preparar derivados de fenilpiperidina
ES494955A Expired ES8106892A1 (es) 1979-02-23 1980-09-11 Un procedimiento para preparar derivados de fenilpiperidina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES488708A Granted ES488708A0 (es) 1979-02-23 1980-02-18 Un procedimiento para preparar derivados de fenilpiperidina

Country Status (7)

Country Link
US (1) US4216218A (es)
EP (1) EP0014997B1 (es)
JP (1) JPS55147258A (es)
AT (1) ATE4203T1 (es)
CA (1) CA1142522A (es)
DE (1) DE3064183D1 (es)
ES (2) ES488708A0 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312876A (en) * 1979-02-23 1982-01-26 Hoechst-Roussel Pharmaceuticals Incorporated Antidepressive and analgesic 4-aryloxy- and 4-arylthio-3-phenylpiperidines
US4333942A (en) * 1979-08-03 1982-06-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Anti-depressant and analgesic 4-phenoxypiperidines
US4387230A (en) * 1979-09-06 1983-06-07 John Wyeth And Brother Limited Process for preparing a dihydropyridine derivative
US4496732A (en) * 1983-03-14 1985-01-29 Hoechst-Roussel Pharmaceuticals Inc. Stereoselective reduction of 2- or 3-substituted 4-piperidones with sodium borohydride
US4529732A (en) * 1983-03-14 1985-07-16 Pfizer Inc. 2-[2-Hydroxy-4-(substituted)phenyl]piperidines
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US6162927A (en) * 1994-08-19 2000-12-19 Abbott Laboratories Endothelin antagonists
US7208517B1 (en) 1994-08-19 2007-04-24 Abbott Labortories Endothelin antagonists
US6124341A (en) * 1996-02-13 2000-09-26 Abbott Laboratories Endothelin antagonists
CN1222513C (zh) 1997-02-03 2005-10-12 富士写真菲林株式会社 卤化银彩色照相感光材料和其中所用的菲尼酮化合物以及这类化合物的制备方法
US20020055457A1 (en) * 2000-08-07 2002-05-09 Janus Todd J. Methods of treating cancer and the pain associated therewith using endothelin antagonists
DE10201550A1 (de) * 2002-01-17 2003-07-31 Merck Patent Gmbh Phenoxy-Piperidine
JP2007537233A (ja) * 2004-05-12 2007-12-20 ファイザー・プロダクツ・インク Nk1及びnk3アンタゴニストとしてのピペリジン誘導体
US8865906B2 (en) * 2009-05-15 2014-10-21 Sanofi Process for the preparation of a compound useful as an inhibitor of TAFIa
CN116057038B (zh) * 2020-09-11 2025-12-12 大金工业株式会社 丙烯酸衍生物的制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3542794A (en) * 1969-11-07 1970-11-24 Grover Cleveland Helsley 1-carbamoyl-4-phenoxypiperidines
DE2116316A1 (de) * 1970-04-08 1971-10-28 Sandoz Ag, Basel (Schweiz) Verfahren zur Herstellung neuer heterocyclischer Verbindungen
US3743645A (en) * 1970-10-19 1973-07-03 Robins Co Inc A H 1-substituted-4-phenoxypiperidines
US4132709A (en) * 1976-12-20 1979-01-02 Ayerst, Mckenna & Harrison, Ltd. [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor

Also Published As

Publication number Publication date
JPH0243740B2 (es) 1990-10-01
ES8106892A1 (es) 1981-09-01
US4216218A (en) 1980-08-05
EP0014997A1 (en) 1980-09-03
ES8102097A1 (es) 1980-12-16
ATE4203T1 (de) 1983-08-15
CA1142522A (en) 1983-03-08
ES488708A0 (es) 1980-12-16
EP0014997B1 (en) 1983-07-20
DE3064183D1 (en) 1983-08-25
JPS55147258A (en) 1980-11-17

Similar Documents

Publication Publication Date Title
ES488708A0 (es) Un procedimiento para preparar derivados de fenilpiperidina
ES489220A0 (es) Un procedimiento para la preparacion de derivados del indol.
ES516286A0 (es) "un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina".
AR224008A1 (es) Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato
AR227766A1 (es) Procedimiento para preparar nuevas pirixolo-1,5-a-pirimidinas sustituidas
DE3060568D1 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
SE8005943L (sv) Piperazinderivat som cirkulationsforhojande emne
ES490290A0 (es) Un procedimiento para la preparacion de derivados de tioxan tina.
DE3070735D1 (en) 4-aryloxy-3-phenylpiperidine derivatives, intermediates, a process for the preparation of such compounds and their use as medicaments
ES488709A0 (es) Procedimiento para la preparacion de compuestos diorganomag-nesicos,r2mg
AR229087A1 (es) Procedimiento para preparar derivados de 4-(substituido)tio-1-beta-d-ribofuranosilpirazolo(3,4-d)pirimidina
ES490031A0 (es) Procedimiento para la preparacion de nuevos derivados de prostaglandina
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
ES487215A0 (es) Un procedimiento para la preparacion de 1-(3-bromo-isoxa- zol-5-il)-2-tercibutilaminoetanol
ES498146A0 (es) Un procedimiento para preparar derivados de 2,2-dicloroace- tamida
ES494765A0 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol.
ZA817646B (en) 5-phenyltetrazoles containing basic substituents,a process for their preparation and their use as drugs
ES497206A0 (es) Un procedimiento para la preparacion de nuevos derivados de 1,1'-bifenil-2-il-alquilamina
ES468417A1 (es) Procedimiento para la obtencion de derivados de azucar-teo- filina no glicosidicos.
ES533688A0 (es) Un procedimiento para preparar un derivado de aminoprpilaminobleomicina
ES498188A0 (es) Procedimiento para la preparacion de 10-bromoisosandwicina
ES497435A0 (es) Procedimiento para preparar derivados de 2,5-dialcohilfeni- lurea
MX5962E (es) Procedimiento para preparar derivados 1-(substituido)de la 6,7-dimetoxi-isoquinolina
ES495190A0 (es) Un procedimiento para preparar un derivado de 6-fluoro-1,8- naftiridina
ES495828A0 (es) Procedimiento para preparar derivados de s-fenilseleno-bencimidazol.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960506